The authors of a clinical study of an herbal medication have retracted after it became clear that one of the study authors had included two figures without the consent of his co-investigators.
The paper was a study of Green Cross Corporation of Korea’s SHINBARO, which was approved last year for the treatment of osteoarthritis by the Korean FDA.
The editors of the Archives of Pharmacal Research, where the research found a home, ran this notice: Continue reading Herbal arthritis remedy study retracted for “copyright issues”